Hearing Loss Association of America (HLAA) is hosting a one-hour webinar on April 8 2021 as an overview of the FDA drug development process. The webinar content will focus attention on the value of the FDA’s Patient-Focused Drug Development (PFDD) meetings. A PFDD on sensorineural hearing loss is scheduled for May 25, 2021.  HLAA hopes to spike interest in being part of the upcoming FDA-sponsored PFDD for the hearing loss community. The sessions are free.

HLAA’s press release about their April 8 webinar is [here], with the webinar program described [here]. HLAA expects to provide additional details about the May 25 PFDD as that date approaches.